Mbx Biosciences, Inc. · NASDAQ:MBX
Frazier Life Sciences X, L.P. reported a 11.70% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Sep 26, 2025 · Filed Sep 30, 2025
Frazier Life Sciences X, L.P. reported a 11.70% stake in Mbx Biosciences, Inc., 5,219,440 shares, with active intent on Sep 26, 2025. Filed Sep 30, 2025 (Schedule 13D/A).
- Stake
- 11.70%
- Shares
- 5,219,440
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 2.50% | 1,103,920 |
| FHMLSP, L.P. | 2.50% | 1,103,920 |
| FHMLSP, L.L.C. | 2.50% | 1,103,920 |
| Frazier Life Sciences Public Overage Fund, L.P. | 0.70% | 325,653 |
| FHMLSP Overage, L.P. | 0.70% | 325,653 |
| FHMLSP Overage, L.L.C. | 0.70% | 325,653 |
| Frazier Life Sciences X, L.P. | 11.70% | 5,219,440 |
| FHMLS X, L.P. | 11.70% | 5,219,440 |
| FHMLS X, L.L.C. | 11.70% | 5,219,440 |
| Frazier Life Sciences XI, L.P. | 0% | 3,000 |
| FHMLS XI, L.P. | 0% | 3,000 |
| FHMLS XI, L.L.C. | 0% | 3,000 |
| James N. Topper | 11.70% | 5,219,440 |
| Patrick J. Heron | 11.70% | 5,224,095 |
Source
Related
- Mbx Biosciences, Inc.
- Frazier Life Sciences X, L.P.
- Mbx Biosciences, Inc. shareholders
- Schedule 13D/A · Frazier Life Sciences X, L.P. · Aug 20, 2025
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026